Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market to attain USD 2,829.3 million by 2028

By Sachin Pashte  | Date: January 03, 2023

Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market to attain USD 2,829.3 million by 2028

Report findings suggest that global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market was valued at USD 1,388.8 million in 2021 and is expected to reach USD 2,829.3 million by 2028, showcasing a 10.7% CAGR during the forecast period.

‘Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market’ study includes evaluations of significant product groups and geographical areas in addition to detailed market information. An accurate image of the current situation is presented in the study by carefully examining a number of factors, such as macroeconomic conditions, the environment, governmental policies, along with the latest trends. The research also provides an in-depth analysis of the leading corporate titans, including information on their financial standing, product lines, and significant innovations.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/5652103/

COVID-19 Impact:

Global irritable bowel syndrome with diarrhea (IBS-D) drugs market suffered from the recent coronavirus outbreak as lack of labor, logistical challenges, material scarcity, and other issues hampered the industry's growth and had an impact on many end-use sectors as well. Due to the numerous precautionary lockdowns imposed by governments to stop the spread of disease, there were serious interruptions in various production and supply chain operations, which resulted in significant financial losses for the market.

However, it is projected that in the forthcoming years, the situation for the industry will improve due to efficient immunization efforts and a number of initiatives undertaken by prominent players.

Segmentation & Regional Overview:

In terms of type, worldwide irritable bowel syndrome with diarrhea (IBS-D) drugs market is bifurcated into lotronex, viberzi, XIFAXAN, and others. On the basis of application ambit, the business sphere is branched into retail pharmacy, hospitals pharmacy, and others.

Concerning the regional terrain, the industry spans across Asia-Pacific (India, New Zealand, China, Singapore, Japan, Australia, rest of APAC), Middle East & Africa (Africa, Saudi Arabia, UAE, Iran, Turkey, rest of MEA), North America (Canada, U.S., Mexico), South America (Brazil, Argentina, rest of SA), and Europe (U.K., Germany, Italy, Russia, France, Spain, rest of Europe).

Competitive dashboard:

The major firms in global irritable bowel syndrome with diarrhea (IBS-D) drugs industry are Chongqing Pharscin Pharmaceutical Co., Ltd., Amneal Pharmaceuticals, Astellas Pharma Inc., Sebela Pharmaceuticals Inc., Allergan plc, and Bausch Health Companies Inc.

FAQs:

How are the different segments in global irritable bowel syndrome with diarrhea (IBS-D) drugs market bifurcated by type?

A: Lotronex, viberzi, XIFAXAN, and others are the types assessed in global irritable bowel syndrome with diarrhea (IBS-D) drugs market report.

Which are the prominent companies influencing global irritable bowel syndrome with diarrhea (IBS-D) drugs market dynamics?

A: The major firms in global irritable bowel syndrome with diarrhea (IBS-D) drugs market are Chongqing Pharscin Pharmaceutical Co., Ltd., Amneal Pharmaceuticals, Astellas Pharma Inc., Sebela Pharmaceuticals Inc., Allergan plc, and Bausch Health Companies Inc.

Which are the pivotal regions of the worldwide irritable bowel syndrome with diarrhea (IBS-D) drugs market?

A:  Asia-Pacific (India, New Zealand, China, Singapore, Japan, Australia, rest of APAC), Middle East & Africa (Africa, Saudi Arabia, UAE, Iran, Turkey, rest of MEA), North America (Canada, U.S., Mexico), South America (Brazil, Argentina, rest of SA), and Europe (U.K., Germany, Italy, Russia, France, Spain, rest of Europe.) are the key regions contributing to global irritable bowel syndrome with diarrhea (IBS-D) drugs market revenue.

Which are the basic applications of global irritable bowel syndrome with diarrhea (IBS-D) drugs market?

A: Retail pharmacy, hospitals pharmacy, and others are among the applications of this industry reviewed in the research.

How is global irritable bowel syndrome with diarrhea (IBS-D) drugs market likely to perform during 2022-2028?

A: Global irritable bowel syndrome with diarrhea (IBS-D) drugs market is expected to reach USD 2829.3 million by 2028, showing a 10.7% CAGR during the forecast period.

For More Details on This Report @ https://www.marketstudyreport.com/reports/global-irritable-bowel-syndrome-with-diarrhea-ibs-d-drugs-market-research-report-2022-forecast-upto-2028

About Us:

Market Study Report is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, is the platform that can help you in achieving any of these objectives.

Contact Us:

Ritesh Tiwari
Head - Press and Media
Email: [email protected]   
Phone: 1-866-764-2150
MarketStudyReport.com

About Author

Sachin Pashte     ibmag.com

Sachin Pashte

Sachin is into market research and web marketing since the last 2 years and has worked on multiple projects across various industries. He has expertise in writing promotional content for market research reports while his personal interests include the games of footbal...

Read More